Skip to content

13F-HR filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-12, with 50 holding rows worth $150,076,000.

Accession
0001618205-19-000006
Filed
2019-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 0 entries on the cover page, a total value of $150,076,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $150,076,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM699,648$69,475,000thousands by filing date
Accelerate Diagnostics00430H102COM2,183,795$40,553,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM55,000$4,956,000thousands by filing date
EQM MIDSTREAM PARTNERS LP26885B100UNIT LTD PARTN101,250$3,311,000thousands by filing date
QUIDEL CORP74838J101COM48,844$2,997,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS170,303$2,832,000thousands by filing date
Bristol-Myers Squibb Company110122108COM47,000$2,383,000thousands by filing date
VERMILLION INC92407M206COM NEW3,221,933$1,683,000thousands by filing date
DOVA PHARMACEUTICALS INC25985T102COM50,000$1,398,000thousands by filing date
MASIMO CORP COM574795100Stock8,000$1,190,000thousands by filing date
BIOGEN INC COM09062X103Stock5,000$1,164,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM80,000$1,062,000thousands by filing date
HARROW INC415858109COM180,000$1,012,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW22,000$1,007,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM40,000$911,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW59,000$894,000thousands by filing date
MYRIAD GENETICS INC62855J104COM30,000$859,000thousands by filing date
DERMIRA INC24983L104COM120,000$767,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK38,000$760,000thousands by filing date
ACCELERON PHARMA INC00434H108COM18,672$738,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM50,000$707,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM70,000$673,000thousands by filing date
ARVINAS INC04335A105COM30,000$647,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM30,000$619,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM40,000$574,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM8,300$551,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM20,000$521,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK30,000$516,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM14,000$504,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,800$478,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK180,000$436,000thousands by filing date
XENCOR INC98401F105COMMON STOCK12,300$415,000thousands by filing date
VERACYTE INC COM92337F107Stock15,767$378,000thousands by filing date
SOLENO THERAPEUTICS INC834203101COM240,598$361,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM30,000$348,000thousands by filing date
XBIOTECH INC98400H102COM30,000$314,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM38,000$305,000thousands by filing date
SIENTRA INC82621J105COM40,000$259,000thousands by filing date
CONTINENTAL RES INC212015101COM8,000$246,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK80,000$241,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN77,570$231,000thousands by filing date
ENCANA CORP292505104COM49,550$228,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW10,000$114,000thousands by filing date
WORKHORSE GROUP INC98138J206COM NEW25,000$88,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock15,000$84,000thousands by filing date
CONTRAFECT CORP212326102COM227,003$81,000thousands by filing date
LIVENT CORP53814L108COM10,000$67,000thousands by filing date
YIELD10 BIOSCIENCE INC98585K102COM123,639$62,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock20,000$57,000thousands by filing date
AEVI GENOMIC MEDICINE INC00835P105COM128,000$19,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-19-000006this filing2019-11-12acceptance time not in the bulk data set